Swiss digital therapy specialist Oviva has raised $21 million in second-round financing to help expand the use of smartphone-based tools designed to help people with diabetes manage their c
Disc Medicine has charted a route to market for bitopertin, its drug candidate for rare disease erythropoietic protoporphyria (EPP), after meeting with the FDA.
